Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Expression of "Spot 14" (THRSP) predicts disease free survival in invasive breast cancer: immunohistochemical analysis of a new molecular marker.

Wells WA, Schwartz GN, Morganelli PM, Cole BF, Gibson JJ, Kinlaw WB.

Breast Cancer Res Treat. 2006 Jul;98(2):231-40. Epub 2006 Mar 22.

PMID:
16552628
[PubMed - indexed for MEDLINE]
2.

Spot 14: A marker of aggressive breast cancer and a potential therapeutic target.

Kinlaw WB, Quinn JL, Wells WA, Roser-Jones C, Moncur JT.

Endocrinology. 2006 Sep;147(9):4048-55. Epub 2006 Jun 29. Review.

PMID:
16809441
[PubMed - indexed for MEDLINE]
3.

Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.

Bos R, van der Groep P, Greijer AE, Shvarts A, Meijer S, Pinedo HM, Semenza GL, van Diest PJ, van der Wall E.

Cancer. 2003 Mar 15;97(6):1573-81.

PMID:
12627523
[PubMed - indexed for MEDLINE]
Free Article
4.

High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer.

Shubbar E, Helou K, Kovács A, Nemes S, Hajizadeh S, Enerbäck C, Einbeigi Z.

BMC Cancer. 2013 Feb 1;13:47. doi: 10.1186/1471-2407-13-47.

PMID:
23374458
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Stromal CD10 expression in invasive breast carcinoma correlates with poor prognosis, estrogen receptor negativity, and high grade.

Makretsov NA, Hayes M, Carter BA, Dabiri S, Gilks CB, Huntsman DG.

Mod Pathol. 2007 Jan;20(1):84-9. Epub 2006 Nov 24.

PMID:
17143263
[PubMed - indexed for MEDLINE]
Free Article
6.

Tissue microarray analyses of G1/S-regulatory proteins in ductal carcinoma in situ of the breast indicate that low cyclin D1 is associated with local recurrence.

Jirström K, Ringberg A, Fernö M, Anagnostaki L, Landberg G.

Br J Cancer. 2003 Nov 17;89(10):1920-6.

PMID:
14612904
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

The "Spot 14" gene resides on the telomeric end of the 11q13 amplicon and is expressed in lipogenic breast cancers: implications for control of tumor metabolism.

Moncur JT, Park JP, Memoli VA, Mohandas TK, Kinlaw WB.

Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6989-94.

PMID:
9618526
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Cyclin D1 in invasive breast carcinoma: favourable prognostic significance in unselected patients and within subgroups with an aggressive phenotype.

Mylona E, Tzelepis K, Theohari I, Giannopoulou I, Papadimitriou C, Nakopoulou L.

Histopathology. 2013 Feb;62(3):472-80. doi: 10.1111/his.12013. Epub 2012 Nov 16.

PMID:
23163571
[PubMed - indexed for MEDLINE]
9.

Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes.

Habibi G, Leung S, Law JH, Gelmon K, Masoudi H, Turbin D, Pollak M, Nielsen TO, Huntsman D, Dunn SE.

Breast Cancer Res. 2008;10(5):R86. doi: 10.1186/bcr2156. Epub 2008 Oct 16.

PMID:
18925950
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Fatty acid synthase expression in Japanese breast carcinoma patients.

Nakamura I, Kimijima I, Zhang GJ, Onogi H, Endo Y, Suzuki S, Tuchiya A, Takenoshita S, Kusakabe T, Suzuki T.

Int J Mol Med. 1999 Oct;4(4):381-7.

PMID:
10493979
[PubMed - indexed for MEDLINE]
11.

Automated image analysis of cyclin D1 protein expression in invasive lobular breast carcinoma provides independent prognostic information.

Tobin NP, Lundgren KL, Conway C, Anagnostaki L, Costello S, Landberg G.

Hum Pathol. 2012 Nov;43(11):2053-61. doi: 10.1016/j.humpath.2012.02.015. Epub 2012 May 29.

PMID:
22647349
[PubMed - indexed for MEDLINE]
12.

Prognostic significance of cyclin D1, β-catenin, and MTA1 in patients with invasive ductal carcinoma of the breast.

Cheng CW, Liu YF, Yu JC, Wang HW, Ding SL, Hsiung CN, Hsu HM, Shieh JC, Wu PE, Shen CY.

Ann Surg Oncol. 2012 Dec;19(13):4129-39. doi: 10.1245/s10434-012-2541-x. Epub 2012 Aug 3.

PMID:
22864797
[PubMed - indexed for MEDLINE]
13.

Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables.

Depowski PL, Rosenthal SI, Brien TP, Stylos S, Johnson RL, Ross JS.

Mod Pathol. 2000 May;13(5):542-7.

PMID:
10824926
[PubMed - indexed for MEDLINE]
Free Article
14.

Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V.

Spataro VJ, Litman H, Viale G, Maffini F, Masullo M, Golouh R, Martinez-Tello FJ, Grigolato P, Shilkin KB, Gusterson BA, Castiglione-Gertsch M, Price K, Lindtner J, Cortés-Funes H, Simoncini E, Byrne MJ, Collins J, Gelber RD, Coates AS, Goldhirsch A; International Breast Cancer Study Group.

Cancer. 2003 Apr 1;97(7):1591-600.

PMID:
12655514
[PubMed - indexed for MEDLINE]
Free Article
15.

S14 protein in breast cancer cells: direct evidence of regulation by SREBP-1c, superinduction with progestin, and effects on cell growth.

Martel PM, Bingham CM, McGraw CJ, Baker CL, Morganelli PM, Meng ML, Armstrong JM, Moncur JT, Kinlaw WB.

Exp Cell Res. 2006 Feb 1;312(3):278-88. Epub 2005 Nov 21.

PMID:
16300755
[PubMed - indexed for MEDLINE]
16.

Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study.

Dedes KJ, Lopez-Garcia MA, Geyer FC, Lambros MB, Savage K, Vatcheva R, Wilkerson P, Wetterskog D, Lacroix-Triki M, Natrajan R, Reis-Filho JS.

Breast Cancer Res Treat. 2010 Dec;124(3):653-66. doi: 10.1007/s10549-010-0816-0. Epub 2010 Mar 6.

PMID:
20213079
[PubMed - indexed for MEDLINE]
17.

Clinical significance of cyclin D1 expression in patients with node-positive breast carcinoma treated with adjuvant therapy.

Pelosio P, Barbareschi M, Bonoldi E, Marchetti A, Verderio P, Caffo O, Bevilacqua P, Boracchi P, Buttitta F, Barbazza R, Dalla Palma P, Gasparini G.

Ann Oncol. 1996 Sep;7(7):695-703.

PMID:
8905027
[PubMed - indexed for MEDLINE]
Free Article
18.

A proof of principle clinical trial to determine whether conjugated linoleic acid modulates the lipogenic pathway in human breast cancer tissue.

McGowan MM, Eisenberg BL, Lewis LD, Froehlich HM, Wells WA, Eastman A, Kuemmerle NB, Rosenkrantz KM, Barth RJ Jr, Schwartz GN, Li Z, Tosteson TD, Beaulieu BB Jr, Kinlaw WB.

Breast Cancer Res Treat. 2013 Feb;138(1):175-83. doi: 10.1007/s10549-013-2446-9. Epub 2013 Feb 16.

PMID:
23417336
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

The expression of cytokeratin 5/6 in invasive lobular carcinoma of the breast: evidence of a basal-like subset?

Fadare O, Wang SA, Hileeto D.

Hum Pathol. 2008 Mar;39(3):331-6. doi: 10.1016/j.humpath.2007.07.014.

PMID:
18261623
[PubMed - indexed for MEDLINE]
20.

LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.

Saha B, Zhang N, Naritoku WY, Tsao-Wei DD, Groshen SL, Carlsson G, Larsson L, Gustavsson B, Chaiwun B, Taylor CR, Imam SA.

Anticancer Res. 2004 Jul-Aug;24(4):2391-400.

PMID:
15330189
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk